Flexible Intermediate Bulk Container Market 2022-2027: Industry Trends, Share, Size and Research Report
1 de Julho de 2022, 8:31 - sem comentários aindaAccording to the latest report by IMARC Group, titled “Flexible Intermediate Bulk Container Market Share: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global flexible intermediate bulk container market reached a value of US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2027, exhibiting a CAGR of 5.3% during 2022-2027.
Download free sample of the report: https://www.imarcgroup.com/flexible-intermediate-bulk-container-market/requestsample
A flexible intermediate bulk container (FIBC) is an industrial packaging material used for storing semi-liquid and dry products. It is convenient, cost-effective, spacious, flexible, and widely utilized for keeping non-toxic products, such as pharmaceuticals, agriculture, rubber, chemicals, food, and petrochemicals. It is currently available in different shapes, sizes, and capacities, based on the requirements of the user.
Considerable growth in the construction industryworldwide represents one of the major factors positively influencing the demand for FIBC to storebuilding materials, such as alloys, steel, carbon black, sand, minerals, and cement. In addition, rising environmental consciousness among individuals, along with a significant increase in the need for biodegradable, lightweight, and bulk packaging materials for transporting pharmaceutical products, is contributing to the market growth. Apart from this, key players are introducing eco-friendly variants and offering customizedsolutions, which is anticipated to drive the adoption of FIBC across the globe.
Migraine Drugs Market 2021-2026: Global Size, Share, Trends and Forecast Report
27 de Maio de 2022, 9:21 - sem comentários aindaAccording to the latest report by IMARC Group, titled “Migraine Drugs Market Share: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, IMARC Group expects the global migraine drugs market to grow at a CAGR of around 12% during 2021-2026.
Migraine drugs refer to medications that are used to reduce the severity of migraines and prevent future attacks. A migraine is a severe, neurological disease with a debilitating headache, characterized by an intense throbbing or pulsing in one area of the head. It is accompanied by sensitivity to light, sound and smell, visual disturbances such as auras, and nausea or vomiting. Migraine drugs do not cure migraines; instead, they treat or relieve these symptoms. There are certain blood pressure medications, as well as some antidepressants, anti-seizure drugs and herbals that are used to reduce the frequency of migraines.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Migraine Drugs Market Trends:
According to the Migraine Trust, migraine is the third most common disease globally, with more than 10% of people getting affected by the condition worldwide. This represents the primary factor that has increased the demand for migraine drugs across the globe. Apart from this, the rising healthcare expenditure and improving reimbursement policies for migraine medications are also acting as growth-inducing factors. Besides this, healthcare providers have made significant advancements in the diagnosis and treatment of migraine. A more advanced treatment modality with mechanism-based therapies, including supraorbital transcutaneous stimulation (STS) and transcranial magnetic stimulation, has been introduced as a preventive therapy for migraine. Additionally, there are many other drugs with novel mechanisms of action or new therapeutic targets, which are in different development stages. Furthermore, for the treatment of the coronavirus disease (COVID-19), market players are testing migraine drugs, which is expected to positively influence the market. For instance, a clinical-stage biopharmaceutical company, Biohaven Pharmaceutical Holding Company Ltd., has been examining Zavegepant to treat acute migraines and has commenced the clinical trial on the same drug to mitigate the neuro-immune consequences among COVID-19 patients.
Request Free Sample Report: https://www.imarcgroup.com/migraine-drugs-market/requestsample
Global Migraine Drugs Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Allergan Plc (Abbvie Inc.), Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Eisai Co. Ltd., Eli Lilly and Company, Endo International Plc, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi SA and Teva Pharmaceutical Industries Limited.
The report has segmented the market on the basis on region, treatment type, drug type, route of administration and distribution channel.
Breakup by Treatment Type:
- Abortive Treatment
- Preventive Treatment
Breakup by Drug Type:
- Triptans
- Ergot Alkaloids
- NSAIDs
- Acetylcholine Inhibitors/ Neurotoxins
- Ditans
- CGRP mAbs
- Others
Breakup by Route of Administration:
- Oral
- Injectable
- Others
Breakup by Distribution Channel:
- Hospital-Based Pharmacies
- Retail Pharmacies
- Others
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/migraine-drugs-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: [email protected]
Website: https://www.imarcgroup.com
Global Faucet Market To Grow At 7.99% During 2022-2027 | IMARC Group
3 de Maio de 2022, 8:43 - sem comentários aindaAccording to the latest report by IMARC Group, titled “Faucet Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” provide The global faucet market size reached a US$ 24.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 39.8 Billion by 2027, exhibiting at a CAGR of 7.99% during 2022-2027.
The report provides a detailed analysis of the market by type, application, technology, materials, distribution channel and end user. Also, the report analyzes the market’s competitive landscape.
Download free sample of the report: https://www.imarcgroup.com/faucet-market/requestsample
Faucet Market Industry Definition and Application:
A faucet is a plumbing fixture that regulates the flow of liquid from a pipe or opening or closing a tap. It is made with brass, die-cast zinc, steel, and chrome-plated plastic. Nowadays, a faucet is available in different colors, styles and finishing that can be customized according to user requirements.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Faucet Market Trends and Drivers:
The construction of modernized bathrooms primarily drives the global faucet market. Due to this, several manufacturers are focusing on developing advanced technology-driven plumbing fixtures. For instance, they are introducing digital and hybrid faucets that are smart, touch-free. and designed with scratch and tarnish-resistant surfaces. With the inflating income levels and improving living standards, consumers are willing to spend more on luxurious, esthetically appealing and ergonomically designed faucets. Moreover, rapid urbanization and rising household units have led to an escalated demand for advanced sanitary fittings like faucets. On account of these factors, the market is anticipated to exhibit positive growth in the coming years.
Faucet Market Segmentation:
The report has segmented the market on the basis on type, application, technology, materials, distribution channel and end user.
Breakup by Type:
One Hand Mixer
Two Hand Mixer
Others
Breakup by Application:
Bathroom
Kitchen
Others
Breakup by Technology:
Cartridge
Compression
Ceramic Disc
Ball
Breakup by Materials:
Metal
Plastics
Breakup by Distribution Channel:
Online
Offline
Breakup by End User:
Residential
Commercial
Industrial
Breakup by Region:
North America:( United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico,Others)
Middle East and Africa
Browse full report with TOC: https://bit.ly/3L6CpcH
Who are the Major Faucet Market Key players?
The report provides a detailed analysis of the market leaders, including.
American Standard Brands (Lixil Group), Colston Bath, Delta Faucet Company (Masco Corporation), Franke Holding AG (Artemis Holding AG), Gerber Plumbing Fixtures LLC (Globe Union Group Inc.), Grohe America Inc., Jaquar, Kohler Co., Moen Incorporated (Fortune Brands Home & Security Inc.), Toto Ltd. and Villeroy & Boch Aktiengesellschaft.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
Olivia Anderson
Marketing Manager
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Website: https://www.imarcgroup.com
LinkedIn: https://in.linkedin.com/company/imarc-group
Facial Injectables Market 2021-26: Share, Size, Growth, Trends And Research Report
2 de Maio de 2022, 7:52 - sem comentários aindaAccording to the latest report by IMARC Group, titled “Facial Injectables Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global facial injectables market is expected to grow at a CAGR of around 11% during the forecast period (2021-2026).
Facial injectables, or derma fillers, are gel-like synthetic or naturally occurring substances injected in the folds, lines, and tissues of the face for cosmetic and therapeutic procedures. They are used for enhancing facial contours, plumping cheeks and lips, correcting acne scars and minimizing the visibility of smile lines. Some commonly used facial injectables include collagen, hyaluronic acid and calcium hydroxyl fillers. In comparison to plastic surgeries, they are usually absorbable and can be altered to provide permanent or temporary results based on the requirement of the consumer.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Facial Injectables Market Trends:
The global facial injectables market is primarily driven by the increasing consciousness among the masses regarding physical appearance and the rising preference for minimally invasive (MI) cosmetic procedures. Moreover, the widespread adoption of hyaluronic acid as a natural filler to maintain healthy moisture levels and reverse skin damage is providing a thrust to the market growth. Product manufacturers are also developing innovative wrinkle relaxers and fillers with lower risks of infections, minimal blood loss and lesser recovery time. Other factors, including the rising geriatric population and increasing expenditure capacities of the consumers, are anticipated to drive the market toward growth.
Request Free Sample Report:
https://www.imarcgroup.com/facial-injectables-market/requestsample
Facial Injectables Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Allergan Plc
- Anika Therapeutics Inc.
- Bloomage BioTechnology
- Johnson & Johnson
- Galderma Pharma S.A.
- Integra LifeSciences
- Ipsen (Mayroy SA)
- Medytox Inc.
- Merz Holding GmbH & Co. KG
- Prollenium Medical Technologies Inc.
- Sanofi
- SciVision Biotech Inc.
- Sinclair Pharma (Huadong Medicine Co. Ltd.)
- Suneva Medical Inc.
- Bausch Health Companies Inc.
The report has segmented the market on the basis on region, product type, application type, application and end user.
Breakup by Product Type:
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymethylmethacrylate Beads (PMMA Microspheres)
- Poly-L-Lactic Acid (PLLA)
- Others
Breakup by Application Type:
- Aesthetics
- Therapeutics
Breakup by Application:
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Others
Breakup by End User:
- Hospitals
- Dermatology Clinics
- Others
Breakup by Region:
- North America: United States, Canada
- Asia Pacific: China, Japan, India, South Korea, Australia, Indonesia, Others
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Others
- Latin America: Brazil, Mexico, Other
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/facial-injectables-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Inhaled Nitric Oxide Market Report 2021-26: Industry Trends, Size, Share, Analysis and Forecast
29 de Abril de 2022, 7:15 - sem comentários aindaAccording to the latest report by IMARC Group, titled “Inhaled Nitric Oxide Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026”, the global inhaled nitric oxide market exhibited moderate growth during 2015-2020 and expects the market to grow at a CAGR of around 6% during 2021-2026.
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that skilled doctors supervise at tertiary neonatal intensive care units (NICUs). It aids in regulating vascular muscle tone and treating hypoxemic respiratory failure among newborn children by enhancing ventilation-perfusion mismatch and minimizing hypertension and elevated pulmonary vascular resistance. Inhaled nitric oxide also assists in decreasing the need for extracorporeal membrane oxygenation (ECMO) and improving oxygenation. Currently, iNO therapy is being increasingly used as a rescue agent for acute respiratory distress syndrome (ARDS) patients.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Inhaled Nitric Oxide Market Trends:
The rising prevalence of various respiratory and other subsequent diseases in newborns, including persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), is driving the inhaled nitric oxide market. Furthermore, the growing geriatric population, who are more prone to atherosclerosis, hypertension, peripheral artery disease, thrombosis, etc., is also augmenting the product demand. Moreover, iNO is gaining immense traction for the treatment of chronic obstructive pulmonary disease (COPD), ARDS, asthma, etc. Additionally, iNO therapy is also being used against coronavirus stains as it helps in improving ventilation/perfusion in patients with severe pneumonia. Besides this, the ongoing research and development (R&D) activities in the healthcare industry are anticipated to bolster the market growth in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/inhaled-nitric-oxide-market/requestsample
Global Inhaled Nitric Oxide Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.
The report has segmented the market on the basis on region and application.
Breakup by Application:
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Others
Breakup by Region:
- North America:( United States, Canada)
- Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico,Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/inhaled-nitric-oxide-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
Company Name: IMARC Group
Email: [email protected]
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group